2'-5'-oligoadenylate trimer has been researched along with morphine in 1 studies
Studies (2'-5'-oligoadenylate trimer) | Trials (2'-5'-oligoadenylate trimer) | Recent Studies (post-2010) (2'-5'-oligoadenylate trimer) | Studies (morphine) | Trials (morphine) | Recent Studies (post-2010) (morphine) |
---|---|---|---|---|---|
590 | 4 | 88 | 44,270 | 5,200 | 8,695 |
Protein | Taxonomy | 2'-5'-oligoadenylate trimer (IC50) | morphine (IC50) |
---|---|---|---|
Delta-type opioid receptor | Mus musculus (house mouse) | 0.2939 | |
Delta-type opioid receptor | Rattus norvegicus (Norway rat) | 0.2278 | |
Kappa-type opioid receptor | Mus musculus (house mouse) | 0.0828 | |
Mu-type opioid receptor | Rattus norvegicus (Norway rat) | 0.0385 | |
Kappa-type opioid receptor | Rattus norvegicus (Norway rat) | 0.0545 | |
Mu-type opioid receptor | Homo sapiens (human) | 0.122 | |
Delta-type opioid receptor | Homo sapiens (human) | 0.1199 | |
Kappa-type opioid receptor | Cavia porcellus (domestic guinea pig) | 0.9308 | |
Kappa-type opioid receptor | Homo sapiens (human) | 0.655 | |
Mu-type opioid receptor | Mus musculus (house mouse) | 0.3305 | |
Mu-type opioid receptor | Cavia porcellus (domestic guinea pig) | 0.202 | |
Beta-2 adrenergic receptor | Cavia porcellus (domestic guinea pig) | 0.25 |
Timeframe | Studies, this research(%) | All Research% |
---|---|---|
pre-1990 | 0 (0.00) | 18.7374 |
1990's | 0 (0.00) | 18.2507 |
2000's | 1 (100.00) | 29.6817 |
2010's | 0 (0.00) | 24.3611 |
2020's | 0 (0.00) | 2.80 |
Authors | Studies |
---|---|
Charubala, R; Henderson, EE; Homan, JW; Martinand-Mari, C; Pfleiderer, W; Reichenbach, NL; Rogers, TJ; Steele, AD; Suhadolnik, RJ | 1 |
1 other study(ies) available for 2'-5'-oligoadenylate trimer and morphine
Article | Year |
---|---|
Inhibition of morphine-potentiated HIV-1 replication in peripheral blood mononuclear cells with the nuclease-resistant 2-5A agonist analog, 2-5A(N6B).
Topics: Adenine Nucleotides; Antiviral Agents; Cells, Cultured; Chemokine CCL2; Chemokine CCL5; Endoribonucleases; Enzyme Activation; HIV Protease Inhibitors; HIV-1; Humans; Interferon-alpha; Interferon-gamma; Leukocytes, Mononuclear; Morphine; Narcotics; Oligoribonucleotides; Protein Synthesis Inhibitors; Reverse Transcriptase Inhibitors; Saquinavir; Virus Replication; Zidovudine | 2002 |